A fourth study used levels of TNF and IL-6 as measures of subclinical inflammation in asymptomatic FDRs of RA patients to investigate the role of the bone biomarkers Dkk1 and sclerostin in joint damage prior to onset of clinical RA (113). Here, SOST is linked to rheumatoid arthritis.